{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:26:52Z","timestamp":1781051212528,"version":"3.54.1"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T00:00:00Z","timestamp":1643587200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["21ek0410055"],"award-info":[{"award-number":["21ek0410055"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,3,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:label\/>\n                  <jats:p>High serum total immunoglobulin E (IgE) levels have been reported in chronic pulmonary aspergillosis (CPA). However, researchers have not verified if they reflect the disease activity. We aimed to compare the serum total IgE levels in CPA cases with high serum IgE during an exacerbation or when stable and examined the IgE expression patterns in the lesions via immunofluorescence staining. From April 2016 to September 2019, we extracted CPA cases with elevated serum total IgE levels based on the criteria of the Infectious Diseases Society of America. We retrospectively analyzed serum total IgE levels and other parameters and eventually extracted 32 cases. The patients\u2019 serum total IgE levels were significantly higher in the exacerbation period than in the stable period (P\u00a0&amp;lt;\u00a0.0001). The median rate of change was 1.76 times (quartile 1.41\u20133.25). In addition, we used surgical specimens of CPA cases with high serum total IgE levels, normal serum total IgE CPA cases, and control surgical specimens and performed immunofluorescence staining with IgE, mast cell tryptase, CD138, and 4,6-diamidino-2-phenylindole. We observed multiple mast cells and plasma cells in the CPA cases regardless of the serum total IgE level. In contrast, multiple IgE-positive cells co-stained with tryptase were observed in CPA cases with high serum total IgE levels. This finding suggested that serum total IgE could serve as a biomarker for evaluating disease severity. Immunofluorescence staining suggested that IgE may play a role in pathogenesis through activation of mast cells by cross-linking in cases of CPA with high serum total IgE levels.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Lay summary<\/jats:title>\n                  <jats:p>High serum total IgE levels are common in chronic pulmonary aspergillosis. This novel study indicated that serum total IgE is a possible biomarker of the disease activity in the aforementioned condition. Immunofluorescence staining indicated a possible role of IgE in disease pathogenesis.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/mmy\/myac006","type":"journal-article","created":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T20:14:32Z","timestamp":1643400872000},"source":"Crossref","is-referenced-by-count":11,"title":["Serum total IgE may be a biomarker among chronic pulmonary aspergillosis patients with elevated serum total IgE levels: A cohort study with pathological evaluations"],"prefix":"10.1093","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3012-826X","authenticated-orcid":false,"given":"Shizuka","family":"Watanabe","sequence":"first","affiliation":[{"name":"Clinical Research Center, National Hospital Organization Tokyo National Hospital, Kiyose-shi, Tokyo, 204-8585, Japan"},{"name":"Department of Respiratory Medicine, University of Tokyo, Bunkyo-ku, Tokyo, 113-8655, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junko","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Center for Pulmonary Diseases, National Hospital Organization Tokyo National Hospital, Kiyose-shi, Tokyo, 204-8585, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maho","family":"Suzukawa","sequence":"additional","affiliation":[{"name":"Clinical Research Center, National Hospital Organization Tokyo National Hospital, Kiyose-shi, Tokyo, 204-8585, Japan"},{"name":"Asthma, Allergy and Rheumatology Center, National Hospital Organization Tokyo National Hospital, Kiyose-shi, Tokyo, 204-8585, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keita","family":"Takeda","sequence":"additional","affiliation":[{"name":"Center for Pulmonary Diseases, National Hospital Organization Tokyo National Hospital, Kiyose-shi, Tokyo, 204-8585, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahoko","family":"Imoto","sequence":"additional","affiliation":[{"name":"Clinical Research Center, National Hospital Organization Tokyo National Hospital, Kiyose-shi, Tokyo, 204-8585, Japan"},{"name":"Department of Respiratory Medicine, University of Tokyo, Bunkyo-ku, Tokyo, 113-8655, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Kitani","sequence":"additional","affiliation":[{"name":"Department of Pathology, National Hospital Organization Tokyo National Hospital, Kiyose-shi, Tokyo, 204-8585, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Fukami","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, National Hospital Organization Tokyo National Hospital, Kiyose-shi, Tokyo, 204-8585, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Sasaki","sequence":"additional","affiliation":[{"name":"Center for Pulmonary Diseases, National Hospital Organization Tokyo National Hospital, Kiyose-shi, Tokyo, 204-8585, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Hebisawa","sequence":"additional","affiliation":[{"name":"Department of Pathology, National Hospital Organization Tokyo National Hospital, Kiyose-shi, Tokyo, 204-8585, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotoshi","family":"Matsui","sequence":"additional","affiliation":[{"name":"Center for Pulmonary Diseases, National Hospital Organization Tokyo National Hospital, Kiyose-shi, Tokyo, 204-8585, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,1,31]]},"reference":[{"key":"2022030323095617900_bib1","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1136\/thoraxjnl-2014-206291","article-title":"The clinical spectrum of pulmonary aspergillosis","volume":"70","author":"Kosmidis","year":"2015","journal-title":"Thorax"},{"key":"2022030323095617900_bib2","doi-asserted-by":"crossref","first-page":"1601062","DOI":"10.1183\/13993003.01062-2016","article-title":"Predictors of mortality in chronic pulmonary aspergillosis","volume":"49","author":"Lowes","year":"2017","journal-title":"Eur Respir J"},{"key":"2022030323095617900_bib3","doi-asserted-by":"crossref","first-page":"e0249455","DOI":"10.1371\/journal.pone.0249455","article-title":"Prognostic factors of chronic pulmonary aspergillosis: a retrospective cohort of 264 patients from Japan","volume":"16","author":"Kimura","year":"2021","journal-title":"PLoS One"},{"key":"2022030323095617900_bib4","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1093\/mmy\/myy070","article-title":"Chronic pulmonary aspergillosis update: a year in review","volume":"57","author":"Barac","year":"2019","journal-title":"Med Mycol"},{"key":"2022030323095617900_bib5","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S1473-3099(15)70006-X","article-title":"British Society for Medical Mycology best practice recommendations for the diagnosis of serious fungal diseases","volume":"15","author":"Schelenz","year":"2015","journal-title":"The Lancet Infectious Diseases"},{"key":"2022030323095617900_bib6","doi-asserted-by":"crossref","first-page":"e479","DOI":"10.1016\/j.ijid.2009.07.011","article-title":"Clinical characteristics and treatment outcomes of chronic necrotizing pulmonary aspergillosis: a review of 43 cases","volume":"14","author":"Nam","year":"2010","journal-title":"Int J Infect Dis"},{"key":"2022030323095617900_bib7","doi-asserted-by":"crossref","first-page":"e0193732","DOI":"10.1371\/journal.pone.0193732","article-title":"Twelve-month clinical outcomes of 206 patients with chronic pulmonary aspergillosis","volume":"13","author":"Bongomin","year":"2018","journal-title":"PLoS One"},{"key":"2022030323095617900_bib8","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.jinf.2010.08.005","article-title":"Intravenous micafungin versus voriconazole for chronic pulmonary aspergillosis: a multicenter trial in Japan","volume":"61","author":"Kohno","year":"2010","journal-title":"J Infect"},{"key":"2022030323095617900_bib9","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.jaip.2018.08.034","article-title":"Is there an overlap in immune response between allergic bronchopulmonary and chronic pulmonary aspergillosis?","volume":"7","author":"Sehgal","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2022030323095617900_bib10","doi-asserted-by":"crossref","first-page":"S265","DOI":"10.1086\/376526","article-title":"Chronic cavitary and fibrosing pulmonary and pleural aspergillosis: case series, proposed nomenclature change, and review","volume":"37","author":"Denning","year":"2003","journal-title":"Clinical Infectious Diseases"},{"key":"2022030323095617900_bib11","first-page":"842","article-title":"Case of chronic necrotizing pulmonary aspergillosis complicated by elevated eosinophils and serum IgE","volume":"48","author":"Morita","year":"2010","journal-title":"Nihon Kokyuki Gakkai Zasshi"},{"key":"2022030323095617900_bib12","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2022030323095617900_bib13","doi-asserted-by":"crossref","first-page":"405","DOI":"10.7326\/0003-4819-86-4-405","article-title":"Clinical and immunologic criteria for the diagnosis of allergic bronchopulmonary aspergillosis","volume":"86","author":"Rosenberg","year":"1977","journal-title":"Ann Intern Med"},{"key":"2022030323095617900_bib14","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/cea.12141","article-title":"Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria","volume":"43","author":"Agarwal","year":"2013","journal-title":"Clin Exp Allergy"},{"key":"2022030323095617900_bib15","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.jaci.2020.08.029","article-title":"New clinical diagnostic criteria for allergic bronchopulmonary aspergillosis\/mycosis and its validation","volume":"147","author":"Asano","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"2022030323095617900_bib16","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.chest.2016.02.640","article-title":"CT imaging assessment of response to treatment in chronic pulmonary aspergillosis","volume":"150","author":"Godet","year":"2016","journal-title":"Chest"},{"key":"2022030323095617900_bib17","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3389\/fimmu.2012.00146","article-title":"Role and relevance of mast cells in fungal infections","volume":"3","author":"Saluja","year":"2012","journal-title":"Front Immunol"},{"key":"2022030323095617900_bib18","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.4049\/jimmunol.182.2.1119","article-title":"Dectin-2 recognition of house dust mite triggers cysteinyl leukotriene generation by dendritic cells","volume":"182","author":"Barrett","year":"2009","journal-title":"J Immunol"},{"key":"2022030323095617900_bib19","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jaci.2006.09.045","article-title":"Class switch recombination to IgE in the bronchial mucosa of atopic and nonatopic patients with asthma","volume":"119","author":"Takhar","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"2022030323095617900_bib20","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/cea.12287","article-title":"Local increase in IgE and class switch recombination to IgE in nasal polyps in chronic rhinosinusitis","volume":"44","author":"Baba","year":"2014","journal-title":"Clin Exp Allergy"},{"key":"2022030323095617900_bib21","doi-asserted-by":"crossref","first-page":"5904","DOI":"10.4049\/jimmunol.169.10.5904","article-title":"A protease-activated pathway underlying th cell type 2 activation and allergic lung disease","volume":"169","author":"Kheradmand","year":"2002","journal-title":"J Immunol"},{"key":"2022030323095617900_bib22","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/mi.2009.102","article-title":"Link between allergic asthma and airway mucosal infection suggested by proteinase-secreting household fungi","volume":"2","author":"Porter","year":"2009","journal-title":"Mucosal Immunol"},{"key":"2022030323095617900_bib23","doi-asserted-by":"crossref","first-page":"3590","DOI":"10.1128\/IAI.00359-15","article-title":"Evolution of the immune response to chronic airway colonization with aspergillus fumigatus hyphae","volume":"83","author":"Urb","year":"2015","journal-title":"Infect Immun"},{"key":"2022030323095617900_bib24","first-page":"RC05","article-title":"Allergic bronchopulmonary aspergillosis (ABPA)-The high resolution computed tomography (HRCT) chest imaging scenario","volume":"8","author":"Kaur","year":"2014","journal-title":"J Clin Diagn Res"},{"key":"2022030323095617900_bib25","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1378\/chest.07-0808","article-title":"Clinical significance of hyperattenuating mucoid impaction in allergic bronchopulmonary aspergillosis: an analysis of 155 patients","volume":"132","author":"Agarwal","year":"2007","journal-title":"Chest"},{"key":"2022030323095617900_bib26","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.rmed.2016.11.019","article-title":"Beneficial effects of omalizumab therapy in allergic bronchopulmonary aspergillosis: a synthesis review of published literature","volume":"122","author":"Li","year":"2017","journal-title":"Respir Med"}],"container-title":["Medical Mycology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/mmy\/advance-article-pdf\/doi\/10.1093\/mmy\/myac006\/42339681\/myac006.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mmy\/article-pdf\/60\/3\/myac006\/42692412\/myac006.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mmy\/article-pdf\/60\/3\/myac006\/42692412\/myac006.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,3]],"date-time":"2022-03-03T23:10:18Z","timestamp":1646349018000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mmy\/article\/doi\/10.1093\/mmy\/myac006\/6517702"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,31]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3,3]]}},"URL":"https:\/\/doi.org\/10.1093\/mmy\/myac006","relation":{},"ISSN":["1369-3786","1460-2709"],"issn-type":[{"value":"1369-3786","type":"print"},{"value":"1460-2709","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,3]]},"published":{"date-parts":[[2022,1,31]]},"article-number":"myac006"}}